chr17-28042896-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_016231.5(NLK):c.23C>T(p.Ala8Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000118 in 1,523,002 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000011 ( 0 hom. )
Consequence
NLK
NM_016231.5 missense
NM_016231.5 missense
Scores
1
6
12
Clinical Significance
Conservation
PhyloP100: 6.96
Genes affected
NLK (HGNC:29858): (nemo like kinase) Enables ubiquitin protein ligase binding activity. Involved in protein stabilization and transforming growth factor beta receptor signaling pathway. Predicted to be located in cytosol and nucleoplasm. Predicted to be active in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.26788032).
BS2
High AC in GnomAdExome4 at 15 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NLK | NM_016231.5 | c.23C>T | p.Ala8Val | missense_variant | 1/11 | ENST00000407008.8 | NP_057315.3 | |
NLK | XM_005257988.3 | c.23C>T | p.Ala8Val | missense_variant | 1/10 | XP_005258045.1 | ||
NLK | XR_001752526.3 | n.220C>T | non_coding_transcript_exon_variant | 1/9 | ||||
NLK | XR_934482.2 | n.220C>T | non_coding_transcript_exon_variant | 1/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NLK | ENST00000407008.8 | c.23C>T | p.Ala8Val | missense_variant | 1/11 | 1 | NM_016231.5 | ENSP00000384625.3 | ||
NLK | ENST00000582037.2 | c.23C>T | p.Ala8Val | missense_variant | 1/2 | 2 | ENSP00000464656.1 | |||
NLK | ENST00000583517.1 | n.44-192C>T | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151988Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
151988
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000689 AC: 1AN: 145114Hom.: 0 AF XY: 0.0000133 AC XY: 1AN XY: 75228
GnomAD3 exomes
AF:
AC:
1
AN:
145114
Hom.:
AF XY:
AC XY:
1
AN XY:
75228
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000109 AC: 15AN: 1371014Hom.: 0 Cov.: 31 AF XY: 0.0000104 AC XY: 7AN XY: 671508
GnomAD4 exome
AF:
AC:
15
AN:
1371014
Hom.:
Cov.:
31
AF XY:
AC XY:
7
AN XY:
671508
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151988Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74226
GnomAD4 genome
AF:
AC:
3
AN:
151988
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74226
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 21, 2022 | The c.23C>T (p.A8V) alteration is located in exon 1 (coding exon 1) of the NLK gene. This alteration results from a C to T substitution at nucleotide position 23, causing the alanine (A) at amino acid position 8 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.
REVEL
Uncertain
Sift
Uncertain
D;.
Sift4G
Pathogenic
D;T
Polyphen
B;.
Vest4
MutPred
Gain of catalytic residue at A8 (P = 0.0034);Gain of catalytic residue at A8 (P = 0.0034);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at